Quantitative analysis of the expression of a VIP transgene

Molecular Brain Research

Volumn 33, Issue 1, 1995, Pages 47-60

  Tolentino, Paul J ^a,b   Dikkes, Pieter ^a   Tsuruda, Lori ^b,c   Ebert, Karl ^c   Stephen Fink, J ^b   Villa Komaroff, Lydia ^a,b   Lamperti, Edward D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Cryptic promoter; lacZ; Quantitative PCR; Transgene; Vasoactive intestinal polypeptide

Indexed keywords

BETA GALACTOSIDASE; MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT GENE; RNA ANALYSIS; SCHWANN CELL; SMOOTH MUSCLE FIBER; TESTIS; TRANSGENE;

ANIMAL; BASE COMPOSITION; BASE SEQUENCE; BETA-GALACTOSIDASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMAN; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEURONS; POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA;

EID: 0029128986     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00105-2     Document Type: Article

References (73)

1. Expression of a chimeric VIP gene is targeted to the intestine in transgenic mice
2. Day-night variation in prepro VIP/PHI mRNA within the rat suprachiasmatic nucleus
3. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils
4. The herpes simplex virus type 1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter
5. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization
6. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
7. Alternatively polyadenylated vasoactive intestinal peptide mRNAs are differentially regulated at the level of stability
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Vasoactive intestinal polypeptide-immunoreactive neurons in rat visual cortex
10. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators
11. Two types of cholinergic innervation in cortex, one co-localized with VIP
12. Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons
13. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina
14. The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer
15. Vasopressin and oxytocin gene expression in rat testis
16. Transgenic mice expressing β-galactosidase in mature neurons under neuron-specific enolase promoter control
17. Vasoactive intestinal polypeptide (VIP)-containing neurons in the spinal cord of the rat and their projections
18. Lumbar dorsal root ganglia of the cat: a quantitative study of peptide immunoreactivity and cell size
19. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction
20. Vasoactive intestinal peptide (VIP) mRNA expression in rat T and B lymphocytes
21. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos
22. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide
23. Distribution of vasoactive intestinal polypeptide in the central and peripheral nervous systems as revealed by immunocytochemistry
24. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pitu itary adenylate cyclase activating polypeptide (PACAP)
25. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells
26. Neuron-specific expression of the human dopamine β-hydroxylase gene requires both the cAMP-response element and a silencer region
27. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
28. Expression of calcium channel mRNAs in rat pancreatic islets and downregulation after glucose infusion
29. Evidence for neuropeptide Y synthesis in the rat anterior pituitary and the influence of thyroid hormone status: comparison with vasoactive intestinal peptide, substance P, and neurotensin
30. Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism
31. Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary
32. Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse
33. Cellular and molecular mechanisms determining neurotransmitter phenotypes in sympathetic neurons
34. Localization of vasoactive intestinal polypeptide: a critical appraisal
35. Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons
36. Vasoactive intestinal peptide alters membrane potential and cyclic nucleotide levels in retinal horizontal cells
37. Neuropeptide Y-like immunoreactivity in rat cranial parasympathetic neurons: coexistence with vasoactive intestinal peptide and choline acetyltransferase
38. Cholinergic neuron-specific expression of the human choline acetyltransferase gene is controlled by silencer elements
39. Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene
40. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion
41. Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man
42. Organizational principles in the peripheral sympathetic nervous system: Subdivision by coex isting peptides (somatostatin-, avian pancreatic polypeptide-, and vasoactive intestinal polypeptide-like immunoreactive materials)
43. Peptide neurons in the vagus, splanchnic and sciatic nerves
44. Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining
45. The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
46. Vasoactive intestinal peptide as a mediator of intercellular communication in the cerebral cortex: release, receptors, actions, and interactions with norepinephrine
47. Gene expression in rat brain
48. Functional implications of the radial organization of VIP-containing neurons in the neocortex
49. Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP)
50. Distribution of neuropeptides in rat pterygopalatine ganglion: Light and electron microscopic immunohistochemical studies
51. The regulation of neuropeptide expression in rat anterior pituitary following chronic manipulation of estrogen status: a comparison between substance P, neuropeptide Y, neurotensin, and vasoactive intestinal peptide
52. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts
53. Vasoactive intestinal peptide regulation of neuroblast mitosis and survival: role of CAMP
54. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor
55. Effect of vasoactive intestinal peptide (VIP) and other peptides on CAMP accumulation in rat brain
56. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons
57. Neuroendocrine significance of vasoactive intestinal polypeptide
58. Optimizing the northern blot procedure
59. Potent peripheral and splanchnic vasodilator peptide from normal gut
60. Localization of vasoactive intestinal peptide- and peptide histidine isoleucine amide-like immunoreactivities in the rat superior cervical ganglion and its nerve trunks
61. Distribution of peptide- and catecholamine-containing neurons in the gastrointes tinal tract of rat and guinea pig: immunohistochemical studies with antisera to substance P, VIP, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine β-hydroxylase
62. Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition
63. Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor
64. mRNA in the mammalian central nervous system
65. Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line
66. Identification of a region in the human vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP
67. Quantitation of mRNA by the polymerase chain reaction
68. 5′ Flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice
69. Analysis of the mouse protamine 1 promoter in transgenic mice